---
title: "LYNCH THOMAS G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bf94f225-bb59-59df-a67f-22683f148b03
json: https://whiteintel.dev/api/public/dossier/bf94f225-bb59-59df-a67f-22683f148b03
identifier: sec:0001360000
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LYNCH THOMAS G

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001360000`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bf94f225-bb59-59df-a67f-22683f148b03  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bf94f225-bb59-59df-a67f-22683f148b03  

## Ownership & control

### Holdings / subsidiaries

- **EVOFEM BIOSCIENCES, INC.** (director) — https://whiteintel.dev/entity/e8889380-2043-5eff-b6d8-a16129d5c9ca
- **GW PHARMACEUTICALS PLC** (director) — https://whiteintel.dev/entity/c095a8a7-b5a4-5057-993a-c5c64f6189b4

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LYNCH THOMAS G**. Human view: https://whiteintel.dev/entity/bf94f225-bb59-59df-a67f-22683f148b03 · Structured JSON: https://whiteintel.dev/api/public/dossier/bf94f225-bb59-59df-a67f-22683f148b03._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._